Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manisha Prajapat

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Indian Journal of Pharmacology|February 21, 2019
Connectomics: A pharmacologic viewpointDibbanti Harikrishnareddy, Manisha Prajapat, Subodh Kumar, et al.
Indian Journal of Pharmacology|March 24, 2020
Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approachPhulen Sarma, Manisha Prajapat, Pramod Avti, et al.
Medicine|February 13, 2020
Bacteriological pattern and their correlation with complications in culture positive cases of acute bacterial conjunctivitis in a tertiary care hospital of upper Assam: A cross sectional studyAnusuya Bhattacharyya, Phulen Sarma, Bhaswati Sarma, et al.
Indian Journal of Pharmacology|August 22, 2025
In silico drug repurposing targeting fusion and nucleoprotein of human metapneumovirus: A step toward pandemic preparednessHarshita Rajput, Gajendra Choudhary, Hadiya Siddiqui, et al.
Medical Hypotheses|March 4, 2021
Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?Hardeep Kaur, Phulen Sarma, Anusuya Bhattacharyya, et al.
Journal of Biomolecular Structure & Dynamics|October 25, 2023
Integrated in-silico and in-vitro assessments of HDAC6 inhibitor efficacy in mitigating amyloid beta pathology in Alzheimer's diseaseGajendra Choudhary, Manisha Prajapat, Gurjeet Kaur, et al.
Bioinformatics and Biology Insights|July 10, 2023
A Novel Inhibitor of DKK1/LRP6 Interactions Against the Alzheimer Disease: An Insilco ApproachManisha Prajapat, Harvinder Singh, Gajendra Chaudhary, et al.
Indian Journal of Pharmacology|June 14, 2023
Role of intravenous aspirin versus oral aspirin in the treatment of acute coronary syndrome: Answering a clinical query by systematic review and meta-analysis of randomized controlled trialsHardeep Kaur, Phulen Sarma, Anusuya Bhattacharyya, et al.
Metabolic Brain Disease|September 16, 2025
A novel modulator of the Axin/β-Catenin interaction to restore EAAT2 expression in alzheimer's disease: an in-silico and in-vitro approachHarminder Kaur, Biman Saikia, Gajendra Choudhary, et al.
Journal of Alzheimer'S Disease : JAD|July 30, 2025
Therapeutic potential of 6BIO and DKK1-LRP6 inhibitor in Wnt/β-catenin pathway modulation for amyloid-β-induced Alzheimer's disease modelManisha Prajapat, Phulen Sarma, Gurjeet Kaur, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Indian Journal of Pharmacology|February 21, 2019
Connectomics: A pharmacologic viewpointDibbanti Harikrishnareddy, Manisha Prajapat, Subodh Kumar, et al.
Indian Journal of Pharmacology|March 24, 2020
Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approachPhulen Sarma, Manisha Prajapat, Pramod Avti, et al.
Medicine|February 13, 2020
Bacteriological pattern and their correlation with complications in culture positive cases of acute bacterial conjunctivitis in a tertiary care hospital of upper Assam: A cross sectional studyAnusuya Bhattacharyya, Phulen Sarma, Bhaswati Sarma, et al.
Indian Journal of Pharmacology|August 22, 2025
In silico drug repurposing targeting fusion and nucleoprotein of human metapneumovirus: A step toward pandemic preparednessHarshita Rajput, Gajendra Choudhary, Hadiya Siddiqui, et al.
Medical Hypotheses|March 4, 2021
Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?Hardeep Kaur, Phulen Sarma, Anusuya Bhattacharyya, et al.
Journal of Biomolecular Structure & Dynamics|October 25, 2023
Integrated in-silico and in-vitro assessments of HDAC6 inhibitor efficacy in mitigating amyloid beta pathology in Alzheimer's diseaseGajendra Choudhary, Manisha Prajapat, Gurjeet Kaur, et al.
Bioinformatics and Biology Insights|July 10, 2023
A Novel Inhibitor of DKK1/LRP6 Interactions Against the Alzheimer Disease: An Insilco ApproachManisha Prajapat, Harvinder Singh, Gajendra Chaudhary, et al.
Indian Journal of Pharmacology|June 14, 2023
Role of intravenous aspirin versus oral aspirin in the treatment of acute coronary syndrome: Answering a clinical query by systematic review and meta-analysis of randomized controlled trialsHardeep Kaur, Phulen Sarma, Anusuya Bhattacharyya, et al.
Metabolic Brain Disease|September 16, 2025
A novel modulator of the Axin/β-Catenin interaction to restore EAAT2 expression in alzheimer's disease: an in-silico and in-vitro approachHarminder Kaur, Biman Saikia, Gajendra Choudhary, et al.
Journal of Alzheimer'S Disease : JAD|July 30, 2025
Therapeutic potential of 6BIO and DKK1-LRP6 inhibitor in Wnt/β-catenin pathway modulation for amyloid-β-induced Alzheimer's disease modelManisha Prajapat, Phulen Sarma, Gurjeet Kaur, et al.
Pageof 5